Negative regulation of β4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression

Cancer Research

Volumn 69, Issue 14, 2009, Pages 5978-5986

  Bon, Giulia ^a   Di Carlo, Selene E ^a   Folgiero, Valentina ^a   Avetrani, Paolo ^a   Lazzari, Chiara ^a   D'Orazi, Gabriella ^b   Brizzi, Maria Felice ^c   Sacchi, Ada ^a   Soddu, Silvia ^a   Blandino, Giovanni ^a   Mottolese, Marcella ^a   Falcioni, Rita ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA4 INTEGRIN; HISTONE DEACETYLASE; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE B; PROTEIN P300; PROTEIN P53; CARRIER PROTEIN; HIPK2 PROTEIN, HUMAN; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; PROTEIN SERINE THREONINE KINASE;

ANCHORAGE INDEPENDENT GROWTH; ARTICLE; BREAST CARCINOMA; CELL INVASION; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; UPREGULATION; WILD TYPE; BREAST TUMOR; CELL PROLIFERATION; CELL STRAIN HCT116; CELL STRAIN HT29; CYTOPLASM; DISEASE COURSE; FEMALE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; IMMUNOHISTOCHEMISTRY; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY; PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOPLASM; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HISTONE ACETYLTRANSFERASES; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; INTEGRIN BETA4; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; NEOPLASMS; P300-CBP TRANSCRIPTION FACTORS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 67651005198     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0244     Document Type: Article

References (45)

1. 4 integrin promotes carcinoma invasion. Cell 1997;91:949-60.
2. 4 integrin in the mechanisms that regulate breast cancer progression. Breast Cancer Res 2007;9:1-5.
3. 1 integrins associate with ErbB-2 in human carcinoma cell lines. Exp Cell Res 1997;236:76-85.
4. Gambaletta D, Marchetti A, Benedetti L, Mercurio AM, Sacchi A, Falcioni R. Cooperative signaling between α(6)β(4) integrin and ErbB-2 receptor is required to promote phosphatidylinositol 3-kinase-dependent invasion. J Biol Chem 2000;275:10604-10.
5. 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006;126:489-502.
6. 4 signaling and function. Cancer Res 2007;67:1645-52.
7. 4 integrin contributes to tamoxifen resistance in ERh1-negative breast carcinomas. PloS ONE 2008;3:e1592.
8. Perou CM, Sørlie T, Eisen MB, et al. Molecular portraits of human breast tumors. Nature 2000;406:747-52.
9. 4 expression in human breast cancer: association with basal-like tumour and prognostic significance. Clin Cancer Res 2008;14:1050-8.
10. 4 integrin is a transforming molecule that unleashes Met tyrosine kinase tumorigenesis. Cancer Res 2005;65:10674-9.
11. 4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. Clin Cancer Res 2006;12:3280-7.
12. 4 integrin maintains the survival of human breast carcinoma cells in vivo. Cancer Res 2005;65:10970-6.
13. 4 integrin regulation are associated with the initial steps in keratinocyte maturation. Cell Growth Differ 1996;7:615-28.
14. Serini G, Trusolino L, Saggiorato E, et al. Changes in integrin and E-cadherin expression in neoplastic versus normal thyroid tissue. J Natl Cancer Inst 1996;88:442-9.
15. 4 integrin epitopes in the basement membrane zone of normal human skin and basal cell carcinomas. J Invest Dermatol 1992;98:864-70.
16. 4 integrin and laminin-5 in human prostate carcinoma. Prostate 2001;46:240-8.
17. Carrol DK, Carroll JS, Leong CO, et al. p63 regulates and adhesion programme and cell survival in epithelial cells. Nat Cell Biol 2006;8:551-61.
18. Kim YH, Choi CY, Lee SJ. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J Biol Chem 1998;273:25875-9.
19. 46 and mediates apoptosis. Nat Cell Biol 2002;4:11-9.
20. Hofmann TG, Möller A, Sirma H, et al. Regulation of p53 activity by its interaction with homeodomain-interacting protein kinase-2. Nat Cell Biol 2002;4:1-10.
21. Oda K, Arakawa H, Tanaka T, et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000;102:849-62.
22. Cecchinelli B, Lavra L, Rinaldo C, et al. Repression of the anti-apoptotic molecule galectin-3 by HIPK2-activated p53 is required for p53-induced apoptosis. Mol Cell Biol 2006;26:4746-57.
23. Kim EJ, Park JS, Um SJ. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo. J Biol Chem 2002;277:32020-8.
24. Pierantoni GM, Rinaldo C, Mottolese M, et al. Highmobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest 2007;117:693-702.
25. 2 arrest after DNA damage. Science 1998;282:1497-501.
26. 2 generation in human colorectal cancer cells. Clin Cancer Res 2006;12:735-41.
27. Jost CA, Marin MC, Kaelin WG, Jr. p73 is a human p53 related protein that can induce apoptosis. Nature 1997;389:191-4.
28. Di Stefano V, Rinaldo C, Sacchi A, Soddu S, D'Orazi G. Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatinmediated apoptosis. Exp Cell Res 2004;293:311-20.
29. Iacovelli S, Ciuffini L, Lazzari C, et al. Hipk2 is involved in cell proliferation and its suppression promotes growth arrest independently of DNA damage. Cell Prolif 2008;42:373-84.
30. Mottolese M, Orlandi G, Sperduti I, et al. Biopathologic characteristics according to chromosome 11 aneusomy and cyclin D1 gene status in surgically resected stage Iand IIbreast cancer: identification of an adverse prognostic profile. Am J Surg Pathol 2007;31:247-54.
31. Sobin LH, Witteking CH. International Union Against Cancer. TNM classification of malignant tumors. New York: Wiley-Liss; 2002.
32. 4 in the invasive properties of colorectal carcinoma cells. Cancer Res 1996;56:4811-19.
33. Moll UM, Slade N. p63 and p73: role in development and tumor formation. Mol Cancer Res 2004;2:371-86.
34. Chen X, Liu G, Zhu J, Jang J, Nozell S, Wills A. Isolation and characterization of fourteen novel putative and nine known target genes of the p53 family. Cancer Biol Ther 2003;2:55-62.
35. Choi CY, Kim YH, Kwon HJ, Kim Y. The homeodomain protein NK-3 recruits Groucho and histone deacetylase complex to repress transcription. J Biol Chem 1999;274:33194-7.
36. Rinaldo C, Prodosmo A, Siepi F, Soddu S. HIPK2: a multitalented partner for transcription factors in DNA damage and development. Biochem Cell Biol 2007;85:411-8.
37. MacPartlin M, Zeng S, Lee H, et al. p300 regulates p63 transcriptional activity. J Biol Chem 2005;280:30604-10.
38. 4 integrin is required for hemidesmosome formation, cell adhesion and cell survival. J Cell Biol 1996;134:559-72.
39. 4 in epidermal homeostasis and tumorigenesis. Mol Cell Biol 2006;26:2877-86.
40. Enge M, Bao W, Hedström E, Jackson SP, Moumen A, Salivanova G. MDM2-dependent down-regulation of p21 and shRNPK provides a molecular switch between apoptosis and cell cycle arrest induced by pharmacologically reactivated p53. Cancer Cell 2009;15:171-83.
41. Di Como CJ, Urist MJ, Babayan I, et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8:494-501.
42. 4 integrin and epithelial cell migration. Curr Opin Cell Biol 2001;13:541-5.
43. Tomasini R, Tsuchihara K, Wilhelm M, et al. Tap73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev 2008;22:2677-91.
44. Flores ER, Tsai KY, Crowley D, et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002;416:560-4.
45. Puca R, Nardinocchi L, Gal H, et al. Reversible dysfunction of wild-type p53 following homeodomain-interacting protein kinase-2 knockdown. Cancer Res 2008;68:3707-14.